Latest filing published 23 Dec 2024 for enVVeno Medical Corp, €24k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -87.4%Entry US$98.70 · Close at T+365 US$12.43
- -5.9%Entry US$269.15 · Close at T+365 US$253.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Matthew Jenusaitis: trading record in brief
This profile gathers the share dealings of Matthew Jenusaitis across 2 companies, led by ev3 Inc. and enVVeno Medical Corp. We count 15 filings; the first trade dates from 22 January 2007 and the latest from 19 December 2024.
Market trades split into 2 purchases (€32k) and 7 sales (€35k). Sales outweigh purchases by €3,155. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants and 2 option exercises. In 2024 alone, the filings show 1 purchase and no sales.
On 23 December 2024 came the latest disclosure, an open-market purchase for €24k in enVVeno Medical Corp. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew Jenusaitis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,620 shares@ US$2.53100.0% of flowCommon StockSEC:0001493152-24-051172:0Canonical exit: 19 Mar 2025 (T+90)
- 1,041 sharesCommon StockSEC:0001493152-22-026070:0
- 1,042 sharesCommon StockSEC:0001493152-21-022863:0
- 1,300 shares@ US$7.70100.0% of flowCommon Stock, $$0.00001 par valueSEC:0001493152-21-021444:0Canonical exit: 23 Nov 2021 (T+90)
- 62,500 shares0Common StockSEC:0001493152-20-019736:0
- 30,000 shares0Common StockSEC:0001235802-08-000053:0
- 342 shares@ US$14.91Common StockSEC:0001235802-07-000184:0
- 342 shares@ US$14.95Common StockSEC:0001235802-07-000184:1
- 1,086 shares@ US$15.00Common StockSEC:0001235802-07-000184:2
- 282 shares@ US$15.01Common StockSEC:0001235802-07-000184:3
- 684 shares@ US$15.08Common StockSEC:0001235802-07-000184:4
- 342 shares@ US$15.09Common StockSEC:0001235802-07-000184:5
- 342 shares@ US$15.38Common StockSEC:0001235802-07-000184:6
- 16,447 shares0Common StockSEC:0001235802-07-000136:0
- 13,687 shares0Common StockSEC:0001235802-07-000012:0
15 of 15 declarations
